3.8 (PMOD Technologies Ltd, Zurich, Switzerland)
Research suggests that the GIP component may help reduce the nausea sometimes associated with GLP-1 medications while potentially enhancing weight loss results
When you deviate significantly below this set point, the hypothalamus activates increasingly aggressive defense mechanisms
Importantly, a substantial number of patients had multiple reasons noted for stopping (21%), underscoring the complexity of real-world medication use and the challenges patients face when using these therapies
GLP-1 reduces appetite, and research has demonstrated that when GLP-1 is administered into the cerebrovascular system of fasting rats, it suppresses their feeding behavior
I would stay motivated for a few weeks, then the cravings would hit, and I would end up right back where I started